Urology practice during the COVID-19 vaccination campaign.

COVID-19 Coronavirus clinical practice guidelines endourology pandemic surgery urology vaccine

Journal

Urologia
ISSN: 1724-6075
Titre abrégé: Urologia
Pays: United States
ID NLM: 0417372

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 14 5 2021
medline: 30 10 2021
entrez: 13 5 2021
Statut: ppublish

Résumé

The current scenario of the COVID-19 pandemic is significantly different from that of the first, emergency phase. Several countries in the world are experiencing a second, or even a third, wave of contagion, while awaiting the effects of mass vaccination campaigns. The aim of this report was to provide an update of previously released recommendations on prioritization and restructuring of urological activities. A large group of Italian urologists directly involved in the reorganization of their urological wards during the first and second phase of the pandemic agreed on a set of updated recommendations for current urology practice. The updated recommendations included strategies for the prioritization of both surgical and outpatient activities, implementation of perioperative pathways for patients scheduled for elective surgery, management of urological conditions in infected patients. Future scenarios with possible implementation of telehealth and reshaping of clinical practice following the effects of vaccination are also discussed. The present update may be a valid tool to be used in the clinical practice, may provide useful recommendations for national and international urological societies, and may be a cornerstone for further discussion on the topic, also considering further evolution of the pandemic after the recently initiated mass vaccination campaigns.

Identifiants

pubmed: 33983086
doi: 10.1177/03915603211016321
pmc: PMC8127017
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-305

Auteurs

Vincenzo Ficarra (V)

Department of Human and Pediatric Pathology "Gaetano Barresi", Urology Section, University of Messina, Messina, Italy.

Giacomo Novara (G)

Department of Surgery, Oncology, and Gastroenterology, Urology Clinic, University of Padua, Padua, Italy.

Gianluca Giannarini (G)

Urology Unit, "Santa Maria della Misericordia" University Hospital, Udine, Italy.

Cosimo De Nunzio (C)

Department of Urology, Sant'Andrea Hospital, Sapienza University of Rome, Roma, Italy.

Alberto Abrate (A)

Department of Surgical, Oncological and Oral Sciences, Urology Section, University of Palermo, Palermo, Italy.

Riccardo Bartoletti (R)

Department of Translational Research and New Technologies, Urology Unit, University of Pisa, Pisa, Italy.

Alessandro Crestani (A)

Urology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

Francesco Esperto (F)

Department of Urology, Campus Bio-Medico University of Rome, Rome, Italy.

Antonio Galfano (A)

Urology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Andrea Gregori (A)

Urology Unit, ASST Fatebenefratelli Sacco, Sacco Hospital, Milan, Italy.

Giovanni Liguori (G)

Department of Urology, Cattinara Hospital, University of Trieste, Trieste, Italy.

Nicola Pavan (N)

Department of Urology, Cattinara Hospital, University of Trieste, Trieste, Italy.

Alchiede Simonato (A)

Department of Surgical, Oncological and Oral Sciences, Urology Section, University of Palermo, Palermo, Italy.

Carlo Trombetta (C)

Department of Urology, Cattinara Hospital, University of Trieste, Trieste, Italy.

Andrea Tubaro (A)

Department of Urology, Sant'Andrea Hospital, Sapienza University of Rome, Roma, Italy.

Francesco Porpiglia (F)

Department of Oncology, Division of Urology, School of Medicine, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy.

Roberto Mario Scarpa (RM)

Department of Urology, Campus Bio-Medico University of Rome, Rome, Italy.

Vincenzo Mirone (V)

Department of Urology, Federico II University of Naples, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH